Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arabs | 8 | 2024 | 187 | 2.960 |
Why?
|
| Housing | 2 | 2024 | 670 | 1.320 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2023 | 591 | 1.090 |
Why?
|
| Brucellosis | 1 | 2022 | 21 | 0.810 |
Why?
|
| Deferoxamine | 1 | 2021 | 154 | 0.760 |
Why?
|
| Iron Chelating Agents | 1 | 2021 | 141 | 0.730 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2020 | 41 | 0.710 |
Why?
|
| Middle East | 4 | 2024 | 231 | 0.680 |
Why?
|
| beta-Thalassemia | 1 | 2021 | 236 | 0.660 |
Why?
|
| Malformations of Cortical Development | 1 | 2020 | 176 | 0.620 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2020 | 155 | 0.620 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 377 | 0.620 |
Why?
|
| Helicobacter Infections | 1 | 2022 | 386 | 0.610 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2022 | 369 | 0.580 |
Why?
|
| Israel | 5 | 2023 | 726 | 0.560 |
Why?
|
| Epilepsy | 2 | 2023 | 3290 | 0.540 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 664 | 0.500 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 822 | 0.480 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 710 | 0.480 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 773 | 0.440 |
Why?
|
| Anemia | 1 | 2022 | 1508 | 0.400 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 1378 | 0.400 |
Why?
|
| Seizures | 2 | 2023 | 2956 | 0.380 |
Why?
|
| Kidney | 1 | 2021 | 7049 | 0.260 |
Why?
|
| Blood Platelets | 1 | 2017 | 2481 | 0.260 |
Why?
|
| Colonialism | 2 | 2023 | 34 | 0.260 |
Why?
|
| Violence | 2 | 2022 | 937 | 0.250 |
Why?
|
| Hemorrhage | 1 | 2017 | 3425 | 0.240 |
Why?
|
| Social Medicine | 1 | 2024 | 64 | 0.230 |
Why?
|
| Goats | 1 | 2022 | 167 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11735 | 0.160 |
Why?
|
| Ferritins | 1 | 2022 | 597 | 0.160 |
Why?
|
| Consanguinity | 1 | 2020 | 456 | 0.160 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 437 | 0.150 |
Why?
|
| Transglutaminases | 1 | 2018 | 197 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 103 | 0.130 |
Why?
|
| Infant, Newborn | 3 | 2023 | 26211 | 0.130 |
Why?
|
| Child | 6 | 2022 | 80156 | 0.130 |
Why?
|
| Familial Mediterranean Fever | 1 | 2016 | 65 | 0.130 |
Why?
|
| Adenosine Diphosphate | 1 | 2017 | 422 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2022 | 1524 | 0.130 |
Why?
|
| Arachidonic Acid | 1 | 2017 | 427 | 0.120 |
Why?
|
| Platelet Function Tests | 1 | 2017 | 271 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2020 | 1626 | 0.120 |
Why?
|
| Humans | 18 | 2024 | 761326 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1273 | 0.110 |
Why?
|
| Child, Preschool | 4 | 2021 | 42251 | 0.110 |
Why?
|
| Epinephrine | 1 | 2017 | 792 | 0.110 |
Why?
|
| Iron | 1 | 2022 | 1792 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2022 | 80575 | 0.100 |
Why?
|
| Poverty | 1 | 2023 | 2697 | 0.100 |
Why?
|
| Curriculum | 1 | 2024 | 3741 | 0.090 |
Why?
|
| Arthritis | 1 | 2016 | 682 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15835 | 0.090 |
Why?
|
| Celiac Disease | 1 | 2018 | 825 | 0.090 |
Why?
|
| Human Rights | 2 | 2022 | 308 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2018 | 2123 | 0.080 |
Why?
|
| Female | 8 | 2023 | 392485 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3469 | 0.080 |
Why?
|
| Infant | 3 | 2020 | 36202 | 0.080 |
Why?
|
| Adolescent | 3 | 2022 | 88305 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4108 | 0.070 |
Why?
|
| Male | 7 | 2022 | 360621 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11070 | 0.070 |
Why?
|
| Risk Factors | 3 | 2023 | 74152 | 0.070 |
Why?
|
| United States | 2 | 2024 | 72317 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2023 | 22124 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5334 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3441 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2016 | 3538 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29858 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39108 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2022 | 386 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23981 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 39974 | 0.040 |
Why?
|
| Young Adult | 1 | 2021 | 59196 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64645 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 30044 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3419 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 168388 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21336 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 220774 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 221122 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10551 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9639 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18401 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15262 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15719 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16603 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41440 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17872 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54405 | 0.010 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_